Imugene Stock Quote IMU - Stock Price, News, Charts, Message Board, Trades

Your Hub for Real-Time streaming quotes, Ideas and Live Discussions

Premium

Current Price

0.036

Bid

0.036

Ask

0.037

Volume

58,353,906

0.035 Day's Range 0.04

0.035 52 Week Range 0.13

Market Cap

263.513M

Previous Close

0.04

Open

0.04

Last Trade

40726

0.037

Last Trade Time

Financial Volume

VWAP

Average Volume (3m)

23,340,780

Shares Outstanding

7,319,810,809

Dividend Yield

PE Ratio

-1.96

Earnings Per Share (EPS)

-0.02

Revenue

4.97M

Net Profit

-149.68M

Sector

Biological Pds,ex Diagnstics

Industry

Biotechnology Animal & Plant

Website

www.imugene.com

Headquarters

Melbourne, Victoria, Aus

Founded

1986

Imugene Limited is listed in the Biological Pds,ex Diagnstics sector of the Australian Stock Exchange with ticker IMU. The last closing price for Imugene was AUD0.04. Over the last year, Imugene shares have traded in a share price range of AUD 0.035 to AUD 0.13.

Imugene currently has 7,319,810,809 shares outstanding. The market capitalization of Imugene is AUD292.79 million. Imugene has a price to earnings ratio (PE ratio) of -1.96.

RenovoRx and Imugene Announce Collaboration to Deliver Oncolytic Virus Therapy Using Proprietary Trans-Arterial Micro-Perfusion (TAMP™) Platform

Collaboration will explore trans-arterial delivery of Imugene’s CF33 oncolytic virus utilizing RenovoRx’s TAMP therapy platform. TAMP is expected to enable localized, targeted delivery of CF33...

Imugene Announces Clinical Trial Supply Agreement with Merck KGaA, Darmstadt, Germany and Pfizer to Evaluate HER-Vaxx in Combination with Avelumab for Treatment of Gastric Cancer

New clinical trial supply agreement with Merck KGaA, Darmstadt, Germany and Pfizer Inc.Avelumab (BAVENCIO®) to be provided to Imugene for Phase 2 clinical study in HER-2 positive gastric or...

Imugene and Eureka Therapeutics Announce Strategic Collaboration to Accelerate Advancement of Oncolytic Virus and T-Cell Therapy in Solid Tumours

The Collaboration will evaluate Eureka’s anti-CD19 ARTEMIS® T-cell therapy in combination with Imugene’s CD19-expressing oncolytic virus onCARlytics in solid tumours Potential to address lack of...

Period	Change	Change %	Open	High	Low	Avg. Daily Vol	VWAP
1	-0.012	-25	0.048	0.048	0.035	21216346	0.04208065	DE
4	-0.014	-28	0.05	0.0525	0.035	17968028	0.04513235	DE
12	-0.018	-33.3333333333	0.054	0.081	0.035	23340780	0.05285731	DE
26	-0.036	-50	0.072	0.081	0.035	19576388	0.05505001	DE
52	-0.052	-59.0909090909	0.088	0.13	0.035	22751405	0.07824016	DE
156	-0.514	-93.4545454545	0.55	0.555	0.035	22862614	0.14699737	DE
260	-0.017	-32.0754716981	0.053	0.625	0.016	21726294	0.16399835	DE

Most Active
% Gainers
% Losers

Symbol	Price	Vol.
HIQOHitIQ Limited	AUD 0.022 (633.33%)	25k
ARDOArgent Minerals Ltd	AUD 0.003 (200.00%)	18.41M
IFGInFocus Group Holdings Ltd	AUD 0.038 (153.33%)	61.11M
ADNOCAndromeda Metals Limited	AUD 0.002 (100.00%)	5M
FNRFar Northern Resources Ltd	AUD 0.18 (71.43%)	142.69k
OECROrbital Corporation Limited	AUD 0.001 (-98.48%)	9
ADXOADX Energy Limited	AUD 0.011 (-63.33%)	875k
CDECodeifai Ltd	AUD 0.001 (-50.00%)	82.68M
CRIOCritica Ltd	AUD 0.001 (-50.00%)	5M
AGEOCAlligator Energy Limited	AUD 0.01 (-28.57%)	36k
SYASayona Mining Limited	AUD 0.034 (-10.53%)	96.47M
CDECodeifai Ltd	AUD 0.001 (-50.00%)	82.68M
88E88 Energy Limited	AUD 0.002 (33.33%)	79.47M
PENPeninsula Energy Ltd	AUD 0.0545 (-3.54%)	72.33M
LPDLepidico Ltd	AUD 0.002 (0.00%)	65.86M